Literature DB >> 14734183

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein.

Dana L Swenson1, Kelly L Warfield, Kathleen Kuehl, Thomas Larsen, Michael C Hevey, Alan Schmaljohn, Sina Bavari, M Javad Aman.   

Abstract

Marburg virus (MARV), the causative agent of a severe hemorrhagic fever, has a characteristic filamentous morphology. Here we report that co-expression of MARV glycoprotein and matrix protein (VP40) in mammalian cells leads to spontaneous budding of filamentous particles strikingly similar to wild-type MARV. In addition, these particles elicit an immune response in BALB/c mice. The generation of non-replicating Marburg virus-like particles (VLPs) should significantly facilitate the research on molecular mechanisms of MARV assembly and release. Furthermore, VLPs may be an excellent vaccine candidate against Marburg infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734183     DOI: 10.1016/S0928-8244(03)00273-6

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  60 in total

1.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

2.  Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles.

Authors:  Olga Dolnik; Larissa Kolesnikova; Lea Stevermann; Stephan Becker
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 3.  Conformational plasticity of the Ebola virus matrix protein.

Authors:  Jens Radzimanowski; Gregory Effantin; Winfried Weissenhorn
Journal:  Protein Sci       Date:  2014-09-04       Impact factor: 6.725

4.  VP24 of Marburg virus influences formation of infectious particles.

Authors:  Sandra Bamberg; Larissa Kolesnikova; Peggy Möller; Hans-Dieter Klenk; Stephan Becker
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

5.  Multivesicular bodies as a platform for formation of the Marburg virus envelope.

Authors:  Larissa Kolesnikova; Beate Berghöfer; Sandra Bamberg; Stephan Becker
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Role of the transmembrane domain of marburg virus surface protein GP in assembly of the viral envelope.

Authors:  Eva Mittler; Larissa Kolesnikova; Thomas Strecker; Wolfgang Garten; Stephan Becker
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

7.  Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP.

Authors:  Shuzo Urata; Takeshi Noda; Yoshihiro Kawaoka; Shigeru Morikawa; Hideyoshi Yokosawa; Jiro Yasuda
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

8.  The glycoprotein cytoplasmic tail of Uukuniemi virus (Bunyaviridae) interacts with ribonucleoproteins and is critical for genome packaging.

Authors:  Anna K Overby; Ralf F Pettersson; Etienne P A Neve
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

9.  Vacuolar protein sorting pathway contributes to the release of Marburg virus.

Authors:  Larissa Kolesnikova; Thomas Strecker; Eiji Morita; Florian Zielecki; Eva Mittler; Colin Crump; Stephan Becker
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

10.  Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice.

Authors:  Nicholas J Lennemann; Andrew S Herbert; Rachel Brouillette; Bethany Rhein; Russell A Bakken; Katherine J Perschbacher; Ashley L Cooney; Catherine L Miller-Hunt; Patrick Ten Eyck; Julia Biggins; Gene Olinger; John M Dye; Wendy Maury
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.